Vertex Pharmaceuticals is a major biopharmaceutical company based in Massachusetts that discovers and sells medicines. Its lobbying filings show it engages with Congress mainly on Medicare and Medicaid policy and health-related issues, including legislation on pain management (the Alternatives to PAIN Act) and budget or tax measures such as FY2025 budget reconciliation and H.R. 1. The company used the firm Marshall & Popp, LLC and reported about $220,000 in spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
HAZEN CLAY MARSHALL
The latest disclosures for this client.
MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MARSHALL & POPP, LLC
MONICA POPP
MARSHALL & POPP, LLC
MARSHALL & POPP, LLC
Q4MARSHALL & POPP, LLC
Q3MARSHALL & POPP, LLC
Q2MARSHALL & POPP, LLC
Q1MARSHALL & POPP, LLC
RR